Company intelligence / Profile preview

Peqish Group

Vancouver, British Columbia, Canadapeqishgroup.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Peqish Group develops clinically-endorsed, functional food products designed to improve well-being and address lifestyle-related diseases. Their offerings are based on scientific research, with some proprietary innovations such as Phyto-P™ (in partnership with Aegis Biopharmaceuticals) targeting inflammation and gut health. The company leverages co-packers for scalable production and has established national distribution agreements[4][5].

Therapeutic areas: Metabolic DisordersImmunologyGastroenterology
Industry: Food & Nutrition

Drug pipeline

2 assets

Phyto-P

Commercial

Indications: General wellness

1 more asset in the full pipeline.

Request access →

Partnerships

Aegis Biopharmaceuticals Inc. (for Phyto-P™, an anti-inflammatory nutraceutical)

Beyond the preview

Go deeper on Peqish Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peqish Group.

Explore the full profile